Test Price
3,000 AED✅ Home Collection Available
Cancer Comprehensive Panel (Genetic NGS Test) in Dubai Healthcare City | 3,000 AED | DNA Labs UAE
Executive Summary & Core Metrics
DHA-Accredited Hereditary Cancer Risk Assessment:
- ✔ Diagnostic Precision: 99.9% sensitivity through ISO-certified Next-Generation Sequencing bioinformatics pipeline.
- ✔ Premium Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
- ✔ Clinical Guidance: Post-test teleconsultation with a DHA-licensed specialist to interpret results and outline next steps.
- ✔ Insurance Verification: Direct coverage check via WhatsApp at +971 54 548 8731 prior to booking.
Test Overview & Methodology
The Cancer Comprehensive Panel (Genetic NGS Test) simultaneously screens over 100 inherited cancer susceptibility genes using advanced Next-Generation Sequencing technology. This single‑draw blood test delivers exceptional accuracy for hereditary cancer risk stratification, enabling proactive surveillance and personalised prevention planning. All analysis is performed in our accredited laboratory under ISO‑validated protocols with board‑certified clinical oversight.
| Feature | Our NGS Panel | Standard Single‑Gene Test |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity | ~95% sensitivity |
| Methodology | NGS multi‑gene panel | Sanger sequencing |
| Report Time | 3–4 weeks | 2–6+ weeks stepwise |
Physician Insight & Safety Protocols
Mr. Prabhakar Reddy Kalathoor (Specialist Diagnostic Radiology – DHA Registration ID: 61713011): “Genetic testing is a powerful tool for early intervention, but it must always be paired with professional clinical interpretation. Patients should understand that a negative result does not eliminate the risk of sporadic cancers, and a positive result guides, not dictates, medical decisions. I urge everyone to discuss results thoroughly with their oncologist before making any health changes.”
Medication Advisory & Precautions
⚠️ Do not discontinue any prescribed medication without explicit approval from your treating physician.
- Informed Consent: Written consent is mandatory prior to sample collection in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Clinical Advisory: Patients undergoing cytotoxic chemotherapy require written clearance from their oncologist before blood draw.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Individuals unable to provide informed written consent, acute febrile illness, severe anaemia (Hb <7 g/dL) unless cleared by the phlebotomist, and those currently undergoing cytotoxic chemotherapy without physician clearance.
- Emergency Red Flags (seek immediate care): Excessive bleeding or haematoma at the venipuncture site, signs of infection (redness, swelling, fever) within 48 hours after sample collection, or sudden allergic reaction following antiseptic use.
Patient FAQ & Clinical Guidance
1. What is a Cancer Comprehensive Panel NGS test?
Our NGS panel analyzes multiple cancer susceptibility genes with 99.9% diagnostic sensitivity and precision. This advanced test detects pathogenic variants in over 100 genes linked to hereditary cancers, enabling proactive surveillance and personalised risk reduction. Results are interpreted by board‑certified genetics professionals and explained during a follow‑up teleconsultation.
2. How is the sample collected and is home collection available in the UAE?
We offer painless, hospital‑grade home blood collection via ISO‑certified cold‑chain logistics. A trained phlebotomist visits your residence at a scheduled time between 8 AM and 11 PM, draws a small volume of peripheral blood, and transports it in temperature‑controlled containers directly to our accredited laboratory. This service is available daily across all seven emirates.
3. How long does it take to get results and how accurate are they?
Results are delivered within 3 to 4 weeks with 99.9% sensitivity and ISO‑validated methodology. The comprehensive analysis undergoes multi‑step bioinformatics verification and board‑certified clinical review, ensuring the highest standard of reliability. A post‑test teleconsultation is included to explain your results and recommend next steps.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under the regulatory oversight of the Dubai Health Authority (DHA Facility License No. 1143). All genetic data is handled in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic information is encrypted, access‑controlled, and used exclusively for diagnostic and preventive healthcare purposes with your explicit written consent.
Clinical & Logistical Metadata
| Test Name | Cancer Comprehensive Panel (Genetic NGS Test) |
| Price (AED) | 3,000 AED |
| Turnaround Time | 21–28 Days (3–4 Weeks) |
| Sample Type / Matrix | Peripheral Whole Blood (3–5 mL in EDTA tube) |
| Methodology Used | Next-Generation Sequencing (NGS) – Multi‑gene Panel |
| ICD-10-CM Code | Z15.09 – Genetic susceptibility to other malignant neoplasm |
| LOINC Code | 51966-8 – Genetic analysis for hereditary cancer panel |
| DHA Facility License & Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians